Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-088-3 | CAS number: 7785-84-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 11.75 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- Dose descriptor starting point:
- NOAEL
- Value:
- 500 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 440.79 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The equation in Figure R. 8-3 of the guidance on information requirements and chemical safety assessment, Chapter R.8 was used to convert the chronic oral NOAEL into a chronic inhalation NOAEC (an absorption value of ratio of 1:2 was used as a worst-case scenario).
- AF for dose response relationship:
- 1
- Justification:
- Default value
- Justification:
- No assessment factor as a chronic study was used to derive the DNEL
- Justification:
- No assessment factor. The allometric scaling factor of 4 was not applied because differences in breathing rate and rat to human body sizes were considered in the conversion from an oral to inhalation threshold data
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor to take into account 'other differences'
- AF for intraspecies differences:
- 5
- Justification:
- Default assessment factor for workers
- AF for the quality of the whole database:
- 3
- Justification:
- Additional assessment factor applied to take into account any uncertainties which might arise from the poor quality of the study from which the NOAEL is derived
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Data available for the derivation of DNELs is from studies on analogous substance pentasodium triphosphate.
The most relevant NOAEC for the long-term DNELs is from the chronic study (Hodge 1959) which has the highest NOAEC below the lowest LOAEC and is therefore considered the most sensitive endpoint -
An assessment factor was applied in the derivation of long term systemic DNELS to take into account:
"Poor quality of study from which the NOAEL is derived (e.g. few animals and inconsistent spacing between doses) also give uncertainty about the statistically derived NOAEL". Hodge dosed at intervals of 0.05%, 0.5% and 5%, the large spacing provides uncertainty about where the true NOAEL might lie.
Conversion from % in diet to mg/kg bw was calculated in accordance with Appendix F of the guidelines for the preparation of toxicological working papers for the joint FAO/WHO expert committee on food additives, December 2000.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.83 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 500 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 287.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The equation in Figure R. 8-3 of the guidance on information requirements and chemical safety assessment, Chapter R.8was used to convert the chronic oral NOAEL into a chronic inhalation NOAEC (an absorption value of ratio of 1:2 was used as a worst-case scenario).
- AF for dose response relationship:
- 1
- Justification:
- Default value
- Justification:
- No assessment factor as a chronic study was used to derive the DNEL
- Justification:
- No assessment factor. The allometric scaling factor of 4 was not applied because differences in breathing rate and rat to human body sizes were considered in the conversion from an oral to inhalation threshold data
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor to take into account 'other differences'
- AF for intraspecies differences:
- 10
- Justification:
- Default assessment factor for the general population
- AF for the quality of the whole database:
- 3
- Justification:
- Additional assessment factor applied to take into account any uncertainties which might arise from the poor quality of the study from which the NOAEL is derived (poorly spaced dose intervals)
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 70 mg/kg bw/day
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Data available for the derivation of DNELs is from studies on analogous substance pentasodium triphosphate.
The most relevant NOAEC for the derivation of the long term DNELs is from the chronic study (Hodge 1959) which has the highest NOAEC below the lowest LOAEC and is therefore considered the most sensitive endpoint -
An assessment factor was applied in the derivation of long term systemic DNELS to take into account:
"Poor quality of study from which the NOAEL is derived (e.g. few animals and inconsistent spacing between doses) also give uncertainty about the statistically derived NOAEL". Hodge dosed at intervals of 0.05%, 0.5% and 5%. The large spacing provides uncertainty about where the true NOAEL might lie.
Conversion from % in diet to mg/kg bw was calculated in accordance with Appendix F of the guidelines for the preparation of toxicological working papers for the joint FAO/WHO expert committee on food additives, December 2000.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
